Skip to Main

2019 Article Archive

UTSW researchers identify new mechanism to reduce inflammation

 

UT Southwestern researchers have identified two proteins that act as gatekeepers to dampen a potentially life-threatening immune response to chronic infection.

A match made in medicine

 

Faculty, family, and friends gathered on the basketball court and watched as more than 200 graduating UT Southwestern medical students joined thousands more at medical schools across the country to reveal their futures.

2019 Match Day Specialty List

 

Grouped by specialty, here are the matches achieved by members of the UT Southwestern Medical School Class of 2019.

Scientists weigh in on debate to quash daylight saving

 

Dr. Joseph Takahashi, who discovered the first circadian gene in mammals (CLOCK), points out that desynchronized body clocks are linked to greater health risks such as obesity, heart attack, cancer, and depression.

$18.4 million in state funding to enhance Simmons Cancer Center research

 

The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center more than $18.4 million for cancer research and faculty recruitment.

A new genetic pathway that prevents early aging

 

Researchers have identified a new genetic pathway that prevents premature aging.

Why every child should see a black male doctor

 

To reverse the trend of declining black men in medicine, we need to convince more black boys to pursue careers in the field.

Luke Perry’s death highlights need for young people to understand stroke symptoms

 

Strokes are caused by sudden blockage of arteries to the brain, and they are often related to diseases such as atherosclerosis (cholesterol buildup) which worsen with age.

UTSW researchers determine structures of elusive innate immunity protein

 

Researchers used cryo-EM to determine the near-atomic structure of the smallest membrane protein solved to date.

Scientists find method to boost CRISPR efficiency

 

Scientists have developed a method to boost the efficiency of CRISPR gene editing in Duchenne muscular dystrophy (DMD), according to a study that could have implications for optimizing gene therapies for other diseases.